The Value of PSMA-RADS Version 2.0 in the Assessment of Pulmonary Metastases in Patients With Prostate Cancer and the Improvement of Differential Diagnosis Efficiency by PSMA PET/CT Parameters
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Prostate cancer (PC) patients with lung opacities can be better assessed using PSMA RADS version 2.0. Integrating PSMA PET/CT parameters with PSMA RADS improves the detection of pulmonary metastases.
Area Of Science
- Nuclear Medicine
- Oncology
- Radiology
Background
- Prostate cancer (PC) management requires accurate staging and detection of metastases.
- Pulmonary involvement in PC can be challenging to differentiate from other lung opacities.
- PSMA PET/CT is a valuable imaging modality for PC, but its role in pulmonary assessment needs further clarification.
Purpose Of The Study
- To evaluate the utility of PSMA RADS version 2.0 for assessing pulmonary metastases in PC patients.
- To determine if PSMA PET/CT parameters offer incremental diagnostic value beyond the PSMA RADS score.
- To analyze CT and PET imaging characteristics for differentiating pulmonary lesions in PC.
Main Methods
- Retrospective analysis of 96 PC patients with pulmonary opacities who underwent 18F-PSMA-BCH PET/CT.
- Assessment of CT features (size, density, smoothness, etc.) and PET parameters (SUVmax, TBR).
- Determination of pulmonary PSMA RADS scores and construction of a parallel diagnostic test for pulmonary metastases.
Main Results
- Of 148 opacities, 54.1% were pulmonary metastases, 32.4% benign, and 13.5% lung cancer.
- SUVmax and smooth edges were independent predictors of metastases (P < 0.05).
- A parallel test combining these parameters achieved an AUC of 0.86, with high diagnostic accuracy across PSMA-RADS scores.
Conclusions
- 18F-PSMA-BCH PET/CT parameters aid in differentiating pulmonary metastases in PC patients.
- Integrating PSMA PET/CT parameters with PSMA RADS version 2.0 provides incremental value for pulmonary metastasis assessment.
- This approach enhances diagnostic accuracy for pulmonary lesions in PC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Radioactive Tracer: PET involves using biologically active molecules labeled with radioactive isotopes, known as tracers or radiotracers. The...
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...